A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
Status:
Completed
Trial end date:
2018-02-06
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the pharmacokinetics, pharmacodynamics, safety,
and tolerability of SB414 in subjects with mild to moderate plaque psoriasis.